Clinical effect of Jiedu Liangxue Jianpi prescription in treatment of patients with hepatitis B virus-associated acute-on-chronic liver failure in early and middle stages

Ke SHI; Yixin HOU; Jie HOU; Yuxin LI; Chongping RAN; Xianbo WANG

doi:10.3969/j.issn.1001-5256.2021.05.018

Volume 37 Issue 5

May 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(5): 1065-1069

PDF( 1888 KB)

Clinical effect of Jiedu Liangxue Jianpi prescription in treatment of patients with hepatitis B virus-associated acute-on-chronic liver failure in early and middle stages

DOI: 10.3969/j.issn.1001-5256.2021.05.018

Ke SHI^{1, 2},
Yixin HOU¹,
Jie HOU^{1, 2},
Yuxin LI¹,
Chongping RAN¹,
Xianbo WANG^{1
,
,}

1.
Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
2.
Department of Gastroenterology, The First Clinical Medical College of Beijing University of Chinese Medicine, Beijing 100700, China

Received Date: 2020-10-18
Accepted Date: 2020-11-23
Published Date: 2021-05-20

Abstract

Abstract

Objective To investigate the clinical effect of Jiedu Liangxue Jianpi prescription in the treatment of patients with hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) in early and middle stages. Methods A total of 75 patients who were diagnosed with HBV-ACLF in early and middle stages in Beijing Ditan Hospital from October 2017 to January 2019 were enrolled and randomly divided into integrated traditional Chinese and Western medicine group with 36 patients and control group with 39 patients. The patients in the control group were given Western medicine treatment, and those in the integrated traditional Chinese and Western medicine group were treated with Jiedu Liangxue Jianpi prescription in addition to Western medicine treatment. The course of treatment was 8 weeks for both groups. Cumulative response rate was observed for both groups, and the two groups were compared in terms of liver function, coagulation function, and routine blood test results before and after treatment. A univariate or multivariate analysis of variance with repeated measures was used for comparison between groups, and the chi-square test was used for comparison of categorical data between two groups. Results At week 4 of treatment, the integrated traditional Chinese and Western medicine group had a significantly higher cumulative response rate than the control group (77.7% vs 53.8%, χ²=4.734, P < 0.05). Compared with the control group, the integrated traditional Chinese and Western medicine group had a significant increase in albumin at weeks 1 and 2 of treatment (all P < 0.05), a significant increase in prothrombin activity at week 1 of treatment (P < 0.05), and significant reductions in neutrophil count and neutrophil-lymphocyte ratio at weeks 3 and 8 of treatment (all P < 0.05). Conclusion Jiedu Liangxue Jianpi prescription can improve the treatment response, liver function, and coagulation function and reduce neutrophil-lymphocyte ratio in patients with HBV-ACLF in early and middle stages.
- Hepatitis B,
- Acute-On-Chronic Liver Failure,
- Drugs, Chinese Herbal

FullText(HTML)

References(14)

References

[1]	SARIN SK, KEDARISETTY CK, ABBAS Z, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J]. Hepatol Int, 2014, 8(4): 453-471. DOI: 10.1007/s12072-014-9580-2.
[2]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[3]	LIU HM, GAO FY, YU H, et al. Analysis of the method of detoxification and cooling blood and invigorating spleen to treat HBV-related acute-on-chronic liver failure[J]. China J Tradit Chin Med Pharma, 2017, 32(2): 440-442. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201702009.htm 刘慧敏, 高方媛, 于浩, 等. 解毒凉血健脾法治疗乙型肝炎慢加急性肝功能衰竭理论探析[J]. 中华中医药杂志, 2017, 32(2): 440-442. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201702009.htm
[4]	WANG XB, LI B, LIU HM, et al. Treatment of hepatitis B virus associated acute-on-chronic liver failure patients by detoxification and cooling blood, strengthening spleen and resolving dampness experience[J]. J Tradit Chin Med, 2012, 53(20): 1772-1776. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201220024.htm 王宪波, 李斌, 刘慧敏, 等. 解毒凉血、健脾化湿法治疗乙型肝炎慢加急性肝功能衰竭体会[J]. 中医杂志, 2012, 53(20): 1772-1776. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201220024.htm
[5]	WANG XB, ZHANG Q, GAO FY. Prediction of acute-on-chronic liver failure and integrated traditional Chinese and western medicine therapy[J]. J Clin Hepatol, 2020, 36(1): 19-25. DOI: 10.3969/j.issn.1001-5256.2020.01.003. 王宪波, 张群, 高方媛. 慢加急性肝衰竭的预后评估及中西医结合治疗[J]. 临床肝胆病杂志, 2020, 36(1): 19-25. DOI: 10.3969/j.issn.1001-5256.2020.01.003.
[6]	LIU HM, WANG XB, WANG RB. Short term efficacy of integrated traditional Chinese and western medicine therapy based on cooling blood and detoxification methods to treat acute-on-chronic hepatitis B liver failure[J]. Chin J Integr Tradit West Med Liver Dis, 2011, 21(4): 197-200. DOI: 10.3969/j.issn.1005-0264.2011.04.002. 刘慧敏, 王宪波, 王融冰. 基于解毒凉血法的中西医结合方案治疗乙型肝炎慢加急性肝衰竭疗效分析[J]. 中西医结合肝病杂志, 2011, 21(4): 197-200. DOI:10.3969/j.issn.1005-0264. 2011.04.002.
[7]	LIU HM, WANG XB, HOU YX, et al. Efficacy and safety of interative medicial program based cooling and detoxification recipe in treating patients with hepatitis B virus related acute-on-chronic liver failure: A randomized controlled clinical study[J]. Chin J Integr Tradit West Med, 2014, 34(4): 412-417. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201404006.htm 刘慧敏, 王宪波, 侯艺鑫, 等. 解毒凉血方加减治疗乙型肝炎慢加急性肝衰竭的随机对照临床研究[J]. 中国中西医结合杂志, 2014, 34(4): 412-417. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201404006.htm
[8]	ZHENG XY. Guiding principles for clinical research of new Chinese Medicine[M]. Beijing: Chinese Medicine Publishing House, 2002: 361-390. 郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 361-390.
[9]	TIAN DL. Internal Medicine of Traditional Chinese Medicine[M]. Beijing: China Press of Traditional Chinese Medicine, 2005: 295-296. 田德禄. 中医内科学[M]. 北京: 中国中医药出版社, 2005: 295-296.
[10]	LEE YM, FERNANDES M, DAC M, et al. The MELD score may help to determine optimum time for liver transplantation[J]. Transplant Proc, 2004, 36(10): 3057-3059. DOI: 10.1016/j.transproceed.2004.11.010.
[11]	GAO FY, WANG XB. Discussion on the effect of strengthening spleen and harmonizing stomach on the treatment of acute-on-chronic hepatic failure[J]. China J Tradit Chin Med Pharma, 2014, 29(4): 1184-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201404068.htm 高方媛, 王宪波. 论健脾和胃法在慢加急性肝衰竭治疗中的作用[J]. 中华中医药杂志, 2014, 29(4): 1184-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201404068.htm
[12]	LIU H, ZHANG H, WAN G, et al. Neutrophil-lymphocyte ratio: A novel predictor for shortterm prognosis in acute-on-chronic hepatitis B liver failure[J]. J Viral Hepat, 2014, 21(7): 499507. DOI: 10.1111/jvh.12160.
[13]	WANG XB, GAO FY, LIU Y, et al. Neutrophil-lymphocyte ratio: A novel predictor of clinical outcome of patients with hepatocellular carcinoma[J]. J Clin Hepatol, 2016, 32(4): 649-652. DOI: 10.3969/j.issn.1001-5256.2016.04.007. 王宪波, 高方媛, 刘尧. 中性粒细胞与淋巴细胞比值: 一项评价肝细胞癌患者预后的新指标[J]. 临床肝胆病杂志, 2016, 32(4): 649-652. DOI: 10.3969/j.issn.1001-5256.2016.04.007.
[14]	LIU HM, GAO FY, JIANG YY, et al. Treatment of hepatitis B with Jiedu Liangxue Lishi decoction combined with Western Medicine Clinical observation of 30 cases of chronic and acute liver failure[J]. J Tradit Chin Med, 2018, 59(1): 41-45. DOI: 10.13288/j.11-2166/r.2018.01.011. 刘慧敏, 高方媛, 江宇泳, 等. 解毒凉血利湿方加减联合西药治疗乙型肝炎慢加急性肝衰竭前期30例临床观察[J]. 中医杂志, 2018, 59(1): 41-45. DOI: 10.13288/j.11-2166/r.2018.01.011.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(4)

Get Citation

PDF

XML

Article Metrics

Article views (574) PDF downloads(33)

Clinical effect of Jiedu Liangxue Jianpi prescription in treatment of patients with hepatitis B virus-associated acute-on-chronic liver failure in early and middle stages

DOI: 10.3969/j.issn.1001-5256.2021.05.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical effect of Jiedu Liangxue Jianpi prescription in treatment of patients with hepatitis B virus-associated acute-on-chronic liver failure in early and middle stages

DOI: 10.3969/j.issn.1001-5256.2021.05.018

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content